Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Visiongain | PRODUCT CODE: 1886178

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 1886178

Pharma Contract Sales Market Report 2025-2035

PUBLISHED:
PAGES: 399 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5872.50
PDF (Team License - Up to 6 Users)
USD 6952.50
PDF (Site License)
USD 8167.50
PDF (Enterprise License - Includes Free Datasets)
USD 10320.75

Add to Cart

Description

Table of Contents

List of Tables

The global Pharma Contract Sales market is projected to grow at a CAGR of 12.3% by 2035

The Pharma Contract Sales Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

CRO-CSO Integration Accelerates End-to-End Commercialisation Models

Pharmaceutical companies are increasingly turning to service providers that can bridge the gap between clinical development and commercial execution. The consolidation of CRO and CSO functions allows for smoother transition from trials to market launch, reducing delays, managing risk, and offering a single point of accountability. This model aligns particularly well with today's global drug launches, where speed, compliance, and scale are essential.

26 August 2025, when EVERSANA merged with Waltz Health to form a unified healthcare platform. By integrating Waltz's drug-price marketplace and direct-to-payer model with EVERSANA's commercialization capabilities, the partnership strengthens drug access strategies while enhancing value delivery. Similarly, on 25 March 2025, Syneos Health signed a Master Commercial Services Agreement with Scienture Holdings, positioning itself as Scienture's dedicated Contract Sales Organisation to manage outsourced field and digital engagement services. This highlights how large players are consolidating their service offerings to provide clients with seamless end-to-end capabilities, reinforcing the global trend toward integrated CRO-CSO platforms.

What would be the Impact of US Trade Tariffs on the Global Pharma Contract Sales Market?

U.S. trade tariffs on pharmaceutical inputs and medical components, particularly those sourced from China, are increasing cost pressures and reshaping how global pharma companies think about commercial models. As margins tighten, originator companies are under greater pressure to reduce fixed commercial overheads, which can accelerate the shift from large in-house sales teams to variable cost, outsourced models. This creates opportunities for Contract Sales Organisations (CSOs) that can offer leaner field forces, more targeted deployment, and strong digital engagement to maintain reach at lower cost. For example, a U.S. biotech facing higher landed costs on Chinese APIs may decide to outsource its secondary care salesforce for a mature brand to a CSO, freeing internal resources to protect launch budgets for newer, higher value products.

Tariffs are also driving supply chain diversification and rerouting, which adds complexity to market access, channel management, and launch planning - areas where CSOs and integrated commercial partners can step in. As companies split sourcing across multiple countries or move some manufacturing closer to end markets, they must navigate different payer systems, distributor structures, and regulatory expectations, often with limited internal local presence. CSOs that combine sales execution with market access support, trade-channel coordination, and data driven territory planning are well placed to manage this complexity. For instance, a multinational shifting part of its API sourcing from China to India and Eastern Europe might rely on regional CSO partners in Europe and Asia to handle hospital engagement, explain any supply or pricing shifts to stakeholders, and protect market share during the transition triggered by tariff changes.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the pharma contract sales market evolving?
  • What is driving and restraining the pharma contract sales market?
  • How will each pharma contract sales submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each pharma contract sales submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading pharma contract sales markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the pharma contract sales projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of pharma contract sales projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the pharma contract sales market?
  • Where is the pharma contract sales market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the pharma contract sales market today, and over the next 10 years:

  • Our 399-page report provides 179 tables and 228 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2035 and other analysis reveal commercial prospects
  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analysis, with business outlooks and developments.
  • Discover qualitative analysis (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharma contract sales prices and recent developments.

Segments Covered in the Report

  • Services
  • Personal Promotion
  • Promotional Sales Team
  • Key Account Management
  • Specialty Sales Teams
  • Vacancy Management
  • Non-personal Promotion
  • Contact Center
  • Tele-detailing
  • Digital Omnichannel Engagement
  • Medical Call Centers
  • Patient Support Programs
  • Telesampling
  • Co-promotion
  • Product Commercialization
  • Marketing Research and Consulting
  • Territory Optimisation and Alignment
  • Market Access and Pricing Support
  • Brand Management
  • Co-promotion Partnerships
  • Mature Product Line Support
  • Support Services
  • Training and Compliance Services
  • Data Analytics and CRM Support
  • Medical Affairs Outsourcing
  • Pharmacovigilance and Safety Monitoring
  • Therapeutic Areas
  • Oncology
  • Immunology
  • Diabetes
  • Cardiovascular Diseases
  • Respiratory Diseases
  • CNS Diseases
  • Others
  • End-users
  • Pharmaceutical Companies
  • Biopharmaceutical Companies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Belgium
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Egypt
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Pharma Contract Sales Market, 2025 to 2035, with a focus on this segment of these companies' operations.

  • Leading companies profiled in the report
  • Amplity, Inc.
  • Apodi
  • Cencora, Inc.
  • CMIC HOLDINGS Co., LTD.
  • EPS Corporation
  • EVERSANA
  • Granard Pharmaceutical Sales & Marketing
  • GTS Solution
  • ICON plc
  • Inizio
  • IQVIA Inc.
  • MaBiCo
  • Marvecs GmbH
  • Mednext Pharma Pvt. Ltd.
  • ONCALL, LLC
  • Peak Pharma Solutions Inc.
  • Promoveo Health
  • QFR Solutions
  • Sales Focus Inc.
  • Sales Partnerships, Inc.
  • SOFIP
  • Syneos Health
  • Uniphar | Global Sourcing
  • VANGUARD PHARMA, LLC

Overall world revenue for Pharma Contract Sales Market, 2025 to 2035 in terms of value the market will surpass US$13.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Pharma Contract Sales Market, 2025 to 2035 report help you?
  • In summary, our 390+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for Pharma Contract Sales Market, 2025 to 2035, with forecasts for services, therapeutic areas, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 27 key national markets - See forecasts for the Pharma Contract Sales Market, 2025 to 2035 in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 24 of the major companies involved in the Pharma Contract Sales Market, 2025 to 2035.
  • Find quantitative and qualitative analysis with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Show more
Product Code: PHA1376

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Pharma Contract Sales Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Significance of Data in Pharma to Drive the Market Demand
      • 3.2.1.2 Global Players Consolidating CRO and CSO Operations to Offer End-to-end Services
      • 3.2.1.3 Transforming Pharma Sales: Technology and Outsourcing in the Pharmaceutical Services Industry
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Quality Challenges in the Competitive Contract Pharma Services Market
      • 3.2.2.2 Navigating Regulatory Hurdles and Timelines in Pharmaceutical Contract Manufacturing
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Rising Opportunities for Pharmaceutical Expansion in Asian Markets
      • 3.2.3.2 Diversification Trends in the Pharma Industry: Increasing Inorganic and Organic Activities to Create Market Opportunities
      • 3.2.3.3 Brand Relaunch and OTC Wellness Expansion
  • 3.3 Impact Analysis
  • 3.4 U.S. Tariffs: What's the Impact on Global Pharma Contract Sales Market?
    • 3.4.1 Overview
    • 3.4.2 V-Shaped Recovery Scenario
      • 3.4.2.1 Why V-Shaped Recovery?
      • 3.4.2.2 Impact from Tariffs
      • 3.4.2.3 Market Dynamics and Demand Recovery
      • 3.4.2.4 Policy and Funding Support
      • 3.4.2.5 Timeframe for Recovery
    • 3.4.3 U Shaped Recovery Scenario
      • 3.4.3.1 Why U-Shaped Recovery?
      • 3.4.3.2 Impact from Tariffs
      • 3.4.3.3 Market Dynamics and Demand Recovery
      • 3.4.3.4 Policy and Funding Support
      • 3.4.3.5 Timeframe for Recovery
    • 3.4.4 L Shaped Recovery Scenario
      • 3.4.4.1 Why L-Shaped Recovery?
      • 3.4.4.2 Impact from Tariffs
      • 3.4.4.3 Market Dynamics and Demand Recovery
      • 3.4.4.4 Policy and Funding Support
      • 3.4.4.5 Timeframe for Recovery
    • 3.4.5 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
    • 3.4.6 Impact of U.S. and China Trade War on Pharma Contract Sales Market
    • 3.4.7 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.5 Porter's Five Forces Analysis
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Competitive Rivalry
    • 3.5.4 Threat from Substitutes
    • 3.5.5 Threat of New Entrants
  • 3.6 PEST Analysis

4 Pharma Contract Sales Market Analysis by Services

  • 4.1 Key Findings
  • 4.2 Services Segment: Market Attractiveness Index
  • 4.3 Pharma Contract Sales Market Size Estimation and Forecast by Services
  • 4.4 Personal Promotion
    • 4.4.1 Personal Promotion Market Size Estimation and Forecast by Type
    • 4.4.2 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.4.3 Market Share by Region, 2025 & 2035 (%)
    • 4.4.4 Promotional Sales Team
      • 4.4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.5 Key Account Management
      • 4.4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.6 Specialty Sales Teams
      • 4.4.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.4.7 Vacancy Management
      • 4.4.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.4.7.2 Market Share by Region, 2025 & 2035 (%)
  • 4.5 Non-personal Promotion
    • 4.5.1 Non-personal Promotion Market Size Estimation and Forecast by Type
    • 4.5.2 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.5.3 Market Share by Region, 2025 & 2035 (%)
    • 4.5.4 Contact Center
      • 4.5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.5 Tele-detailing
      • 4.5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.6 Digital Omnichannel Engagement
      • 4.5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.7 Medical Call Centers
      • 4.5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.7.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.8 Patient Support Programs (PSPs)
      • 4.5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.8.2 Market Share by Region, 2025 & 2035 (%)
    • 4.5.9 Telesampling
      • 4.5.9.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.5.9.2 Market Share by Region, 2025 & 2035 (%)
  • 4.6 Co-promotion
    • 4.6.1 Co-promotion Market Size Estimation and Forecast by Type
    • 4.6.2 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.6.3 Market Share by Region, 2025 & 2035 (%)
    • 4.6.4 Product Commercialization
      • 4.6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.5 Marketing Research and Consulting
      • 4.6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.6 Territory Optimisation & Alignment
      • 4.6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.7 Market Access and Pricing Support
      • 4.6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.7.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.8 Brand Management
      • 4.6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.8.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.9 Co-promotion Partnerships
      • 4.6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.9.2 Market Share by Region, 2025 & 2035 (%)
    • 4.6.10 Mature Product Line Support
      • 4.6.10.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.6.10.2 Market Share by Region, 2025 & 2035 (%)
  • 4.7 Support Services
    • 4.7.1 Support Services Market Size Estimation and Forecast by Type
    • 4.7.2 Market Size by Region, 2025-2035 (US$ Billion)
    • 4.7.3 Market Share by Region, 2025 & 2035 (%)
    • 4.7.4 Training and Compliance Services
      • 4.7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.7.4.2 Market Share by Region, 2025 & 2035 (%)
    • 4.7.5 Data Analytics and CRM Support
      • 4.7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.7.5.2 Market Share by Region, 2025 & 2035 (%)
    • 4.7.6 Medical Affairs Outsourcing
      • 4.7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.7.6.2 Market Share by Region, 2025 & 2035 (%)
    • 4.7.7 Pharmacovigilance and Safety Monitoring
      • 4.7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
      • 4.7.7.2 Market Share by Region, 2025 & 2035 (%)

5 Pharma Contract Sales Market Analysis by Therapeutic Areas

  • 5.1 Key Findings
  • 5.2 Therapeutic Areas Segment: Market Attractiveness Index
  • 5.3 Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 5.4 Oncology
    • 5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.4.2 Market Share by Region, 2025 & 2035 (%)
  • 5.5 Immunology
    • 5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.5.2 Market Share by Region, 2025 & 2035 (%)
  • 5.6 Diabetes
    • 5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.6.2 Market Share by Region, 2025 & 2035 (%)
  • 5.7 Cardiovascular Diseases
    • 5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.7.2 Market Share by Region, 2025 & 2035 (%)
  • 5.8 Respiratory Diseases
    • 5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.8.2 Market Share by Region, 2025 & 2035 (%)
  • 5.9 CNS Diseases
    • 5.9.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.9.2 Market Share by Region, 2025 & 2035 (%)
  • 5.10 Others
    • 5.10.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 5.10.2 Market Share by Region, 2025 & 2035 (%)

6 Pharma Contract Sales Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 6.4 Pharmaceutical Companies
    • 6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.4.2 Market Share by Region, 2025 & 2035 (%)
  • 6.5 Biopharmaceutical Companies
    • 6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
    • 6.5.2 Market Share by Region, 2025 & 2035 (%)

7 Pharma Contract Sales Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Pharma Contract Sales Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Pharma Contract Sales Market Attractiveness Index
  • 8.3 North America Pharma Contract Sales Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 8.4 North America Pharma Contract Sales Market Size Estimation and Forecast by Country
  • 8.5 North America Pharma Contract Sales Market Size Estimation and Forecast by Services
    • 8.5.1 North America Personal Promotion Market Size Estimation and Forecast by Type
    • 8.5.2 North America Non-personal Promotion Market Size Estimation and Forecast by Type
    • 8.5.3 North America Co-promotion Market Size Estimation and Forecast by Type
    • 8.5.4 North America Support Services Market Size Estimation and Forecast by Type
  • 8.6 North America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 8.7 North America Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 8.8 U.S. Pharma Contract Sales Market Analysis
  • 8.9 Canada Pharma Contract Sales Market Analysis

9 Europe Pharma Contract Sales Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Pharma Contract Sales Market Attractiveness Index
  • 9.3 Europe Pharma Contract Sales Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 9.4 Europe Pharma Contract Sales Market Size Estimation and Forecast by Country
  • 9.5 Europe Pharma Contract Sales Market Size Estimation and Forecast by Services
    • 9.5.1 Europe Personal Promotion Market Size Estimation and Forecast by Type
    • 9.5.2 Europe Non-personal Promotion Market Size Estimation and Forecast by Type
    • 9.5.3 Europe Co-promotion Market Size Estimation and Forecast by Type
    • 9.5.4 Europe Support Services Market Size Estimation and Forecast by Type
  • 9.6 Europe Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 9.7 Europe Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 9.8 Germany Pharma Contract Sales Market Analysis
  • 9.9 UK Pharma Contract Sales Market Analysis
  • 9.10 France Pharma Contract Sales Market Analysis
  • 9.11 Italy Pharma Contract Sales Market Analysis
  • 9.12 Spain Pharma Contract Sales Market Analysis
  • 9.13 Russia Pharma Contract Sales Market Analysis
  • 9.14 Switzerland Pharma Contract Sales Market Analysis
  • 9.15 Belgium Pharma Contract Sales Market Analysis
  • 9.16 Rest of Europe Pharma Contract Sales Market Analysis

10 Asia Pharma Contract Sales Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pharma Contract Sales Market Attractiveness Index
  • 10.3 Asia Pharma Contract Sales Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 10.4 Asia Pharma Contract Sales Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Services
    • 10.5.1 Asia Pacific Personal Promotion Market Size Estimation and Forecast by Type
    • 10.5.2 Asia Pacific Non-personal Promotion Market Size Estimation and Forecast by Type
    • 10.5.3 Asia Pacific Co-promotion Market Size Estimation and Forecast by Type
    • 10.5.4 Asia Pacific Support Services Market Size Estimation and Forecast by Type
  • 10.6 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 10.7 Asia Pacific Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 10.8 Japan Pharma Contract Sales Market Analysis
  • 10.9 China Pharma Contract Sales Market Analysis
  • 10.10 India Pharma Contract Sales Market Analysis
  • 10.11 Australia Pharma Contract Sales Market Analysis
  • 10.12 South Korea Pharma Contract Sales Market Analysis
  • 10.13 Singapore Pharma Contract Sales Market Analysis
  • 10.14 Malaysia Pharma Contract Sales Market Analysis
  • 10.15 Rest of Asia Pharma Contract Sales Market Analysis

11 Latin America Pharma Contract Sales Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Pharma Contract Sales Market Attractiveness Index
  • 11.3 Latin America Pharma Contract Sales Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 11.4 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Country
  • 11.5 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Services
    • 11.5.1 Latin America Personal Promotion Market Size Estimation and Forecast by Type
    • 11.5.2 Latin America Non-personal Promotion Market Size Estimation and Forecast by Type
    • 11.5.3 Latin America Co-promotion Market Size Estimation and Forecast by Type
    • 11.5.4 Latin America Support Services Market Size Estimation and Forecast by Type
  • 11.6 Latin America Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 11.7 Latin America Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 11.8 Brazil Pharma Contract Sales Market Analysis
  • 11.9 Mexico Pharma Contract Sales Market Analysis
  • 11.10 Argentina Pharma Contract Sales Market Analysis
  • 11.11 Rest of Latin America Pharma Contract Sales Market Analysis

12 MEA Pharma Contract Sales Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Pharma Contract Sales Market Attractiveness Index
  • 12.3 MEA Pharma Contract Sales Market by Country, 2025, 2030 & 2035 (US$ Billion)
  • 12.4 MEA Pharma Contract Sales Market Size Estimation and Forecast by Country
  • 12.5 MEA Pharma Contract Sales Market Size Estimation and Forecast by Services
    • 12.5.1 MEA Personal Promotion Market Size Estimation and Forecast by Type
    • 12.5.2 MEA Non-personal Promotion Market Size Estimation and Forecast by Type
    • 12.5.3 MEA Co-promotion Market Size Estimation and Forecast by Type
    • 12.5.4 MEA Support Services Market Size Estimation and Forecast by Type
  • 12.6 MEA Pharma Contract Sales Market Size Estimation and Forecast by Therapeutic Areas
  • 12.7 MEA Pharma Contract Sales Market Size Estimation and Forecast by End-users
  • 12.8 GCC Pharma Contract Sales Market Analysis
  • 12.9 South Africa Pharma Contract Sales Market Analysis
  • 12.10 Egypt Pharma Contract Sales Market Analysis
  • 12.11 Rest of MEA Pharma Contract Sales Market Analysis

13 Company Profiles

  • 13.1 Competitive Landscape, 2024
  • 13.2 Strategic Outlook
  • 13.3 Cencora, Inc.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2021-2024
      • 13.3.3.2 Regional Market Shares, 2024
    • 13.3.4 Service Benchmarking
    • 13.3.5 Strategic Outlook
    • 13.3.6 SWOT Analysis
  • 13.4 CMIC HOLDINGS Co., LTD.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2020-2023
    • 13.4.4 Service Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 IQVIA Inc.
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2021-2024
      • 13.5.3.2 Regional Market Shares, 2024
    • 13.5.4 Service Benchmarking
    • 13.5.5 Strategic Outlook
    • 13.5.6 SWOT Analysis
  • 13.6 Syneos Health
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2020-2023
    • 13.6.4 Service Benchmarking
    • 13.6.5 Strategic Outlook
    • 13.6.6 SWOT Analysis
  • 13.7 Inizio
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2021-2024
      • 13.7.3.2 Business Market Shares, 2024
    • 13.7.4 Service Benchmarking
    • 13.7.5 Strategic Outlook
    • 13.7.6 SWOT Analysis
  • 13.8 Uniphar | Global Sourcing
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2021-2024
      • 13.8.3.2 Regional Market Shares, 2024
      • 13.8.3.3 Business Market Shares, 2024
    • 13.8.4 Service Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 ICON plc
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2021-2024
      • 13.9.3.2 Regional Market Shares, 2024
    • 13.9.4 Service Benchmarking
    • 13.9.5 Strategic Outlook
    • 13.9.6 SWOT Analysis
  • 13.10 Amplity, Inc.
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Service Benchmarking
    • 13.10.4 Strategic Outlook
  • 13.11 Apodi
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Service Benchmarking
  • 13.12 Marvecs GmbH
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Service Benchmarking
  • 13.13 ONCALL, LLC
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Service Benchmarking
  • 13.14 SOFIP
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Service Benchmarking
    • 13.14.4 Strategic Outlook
  • 13.15 Granard Pharmaceutical Sales & Marketing
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Service Benchmarking
  • 13.16 VANGUARD PHARMA, LLC
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Service Benchmarking
    • 13.16.4 Strategic Outlook
  • 13.17 GTS Solution
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Service Benchmarking
  • 13.18 MaBiCo
    • 13.18.1 Company Snapshot
    • 13.18.2 Company Overview
    • 13.18.3 Service Benchmarking
  • 13.19 Sales Partnerships, Inc.
    • 13.19.1 Company Snapshot
    • 13.19.2 Company Overview
    • 13.19.3 Service Benchmarking
  • 13.20 QFR Solutions
    • 13.20.1 Company Snapshot
    • 13.20.2 Company Overview
    • 13.20.3 Service Benchmarking
  • 13.21 EPS Corporation
    • 13.21.1 Company Snapshot
    • 13.21.2 Company Overview
    • 13.21.3 Service Benchmarking
  • 13.22 EVERSANA
    • 13.22.1 Company Snapshot
    • 13.22.2 Company Overview
    • 13.22.3 Service Benchmarking
    • 13.22.4 Strategic Outlook
    • 13.22.5 SWOT Analysis
  • 13.23 Mednext Pharma Pvt. Ltd.
    • 13.23.1 Company Snapshot
    • 13.23.2 Company Overview
    • 13.23.3 Service Benchmarking
    • 13.23.4 SWOT Analysis
  • 13.24 Peak Pharma Solutions Inc.
    • 13.24.1 Company Snapshot
    • 13.24.2 Company Overview
    • 13.24.3 Service Benchmarking
  • 13.25 Promoveo Health
    • 13.25.1 Company Snapshot
    • 13.25.2 Company Overview
    • 13.25.3 Service Benchmarking
  • 13.26 Sales Focus Inc.
    • 13.26.1 Company Snapshot
    • 13.26.2 Company Overview
    • 13.26.3 Service Benchmarking
    • 13.26.4 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players
Show more
Product Code: PHA1376

List of Tables

  • Table 1 Pharma Contract Sales Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
  • Table 2 Pharma Contract Sales Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: V- Shaped Recovery Scenario
  • Table 3 Pharma Contract Sales Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: U- Shaped Recovery Scenario
  • Table 4 Pharma Contract Sales Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%), Tariff Impact: L- Shaped Recovery Scenario
  • Table 5 Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 6 Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 7 Personal Promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 8 Promotional Sales Team Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 9 Key Account Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 10 Specialty Sales Teams Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 11 Vacancy Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 12 Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 13 Non-personal Promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 14 Contact Center Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 15 Tele-detailing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 16 Digital Omnichannel Engagement Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 17 Medical Call Centers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 18 Patient Support Programs (PSPs) Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 19 Telesampling Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 20 Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 21 Co-promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 22 Product Commercialization Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 23 Marketing Research and Consulting Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 24 Territory Optimisation & Alignment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 25 Market Access and Pricing Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 26 Brand Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 27 Co-promotion Partnerships Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 28 Mature Product Line Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 29 Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 30 Support Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 31 Training and Compliance Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 32 Data Analytics and CRM Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 33 Medical Affairs Outsourcing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 34 Pharmacovigilance and Safety Monitoring Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 35 Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 36 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 37 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 38 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 39 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 40 Respiratory Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 41 CNS Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 42 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 43 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 44 Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 45 Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 46 Pharma Contract Sales Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 47 North America Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 48 North America Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 49 North America Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 50 North America Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 51 North America Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 52 North America Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 53 North America Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 54 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 55 U.S. Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 56 Canada Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 57 Europe Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 58 Europe Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 59 Europe Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 60 Europe Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 61 Europe Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 62 Europe Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 63 Europe Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 64 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 65 Germany Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 66 UK Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 67 France Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 68 Italy Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 69 Spain Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 70 Russia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 71 Switzerland Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 72 Belgium Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 73 Rest of Europe Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 74 Asia Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 75 Asia Pacific Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 76 Asia Pacific Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 77 Asia Pacific Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 78 Asia Pacific Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 79 Asia Pacific Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 80 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 81 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 82 Japan Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 83 China Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 84 India Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 85 Australia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 86 South Korea Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 87 Singapore Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 88 Malaysia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 89 Rest of Asia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 90 Latin America Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 91 Latin America Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 92 Latin America Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 93 Latin America Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 94 Latin America Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 95 Latin America Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 96 Latin America Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 97 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 98 Brazil Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 99 Mexico Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 100 Argentina Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 101 Rest of Latin America Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 102 MEA Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 103 MEA Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 104 MEA Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 105 MEA Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 106 MEA Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 107 MEA Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 108 MEA Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 109 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 110 GCC Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 111 South Africa Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 112 Egypt Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 113 Rest of MEA Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR%, CAGR%)
  • Table 114 Strategic Outlook
  • Table 115 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Cencora, Inc.: Service Benchmarking
  • Table 117 Cencora, Inc: Strategic Outlook
  • Table 118 Cencora, Inc: SWOT Analysis
  • Table 119 CMIC HOLDINGS Co., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 CMIC Holdings Co. Ltd.: Service Benchmarking
  • Table 121 CMIC Holdings Co. Ltd.: Strategic Outlook
  • Table 122 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 123 IQVIA Inc.: Service Benchmarking
  • Table 124 IQVIA Inc.: Strategic Outlook
  • Table 125 IQVIA Inc.: SWOT Analysis
  • Table 126 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Syneos Health: Service Benchmarking
  • Table 128 Syneos Health: Strategic Outlook
  • Table 129 Syneos Health: SWOT Analysis
  • Table 130 Inizio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 131 Inizio: Service Benchmarking
  • Table 132 Inizio: Strategic Outlook
  • Table 133 Inizio: SWOT Analysis
  • Table 134 Uniphar | Global Sourcing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 Uniphar | Global Sourcing: Service Benchmarking
  • Table 136 Uniphar | Global Sourcing: Strategic Outlook
  • Table 137 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 ICON plc: Service Benchmarking
  • Table 139 ICON plc: Strategic Outlook
  • Table 140 ICON plc.: SWOT Analysis
  • Table 141 Amplity, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 Amplity, Inc.: Service Benchmarking
  • Table 143 Amplity, Inc.: Strategic Outlook
  • Table 144 Apodi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 Apodi: Service Benchmarking
  • Table 146 Marvecs GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 147 Marvecs GmbH: Service Benchmarking
  • Table 148 ONCALL, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 149 ONCALL, LLC: Service Benchmarking
  • Table 150 SOFIP: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 151 SOFIP: Service Benchmarking
  • Table 152 SOFIP: Strategic Outlook
  • Table 153 Granard Pharmaceutical Sales & Marketing: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 154 Granard Pharmaceutical Sales & Marketing: Service Benchmarking
  • Table 155 VANGUARD PHARMA, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 156 VANGUARD PHARMA, LLC: Service Benchmarking
  • Table 157 VANGUARD PHARMA, LLC: Strategic Outlook
  • Table 158 GTS Solution: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 159 GTS Solution: Service Benchmarking
  • Table 160 MaBiCo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 161 MaBiCo: Service Benchmarking
  • Table 162 Sales Partnerships, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 163 Sales Partnerships, Inc.: Service Benchmarking
  • Table 164 QFR Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 165 QFR Solutions: Service Benchmarking
  • Table 166 EPS Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 167 EPS Corporation: Service Benchmarking
  • Table 168 EVERSANA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 169 EVERSANA: Service Benchmarking
  • Table 170 EVERSANA: Strategic Outlook
  • Table 171 EVERSANA: SWOT Analysis
  • Table 172 Mednext Pharma Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 173 Mednext Pharma Pvt. Ltd.: Service Benchmarking
  • Table 174 Mednext Pharma Pvt. Ltd.: SWOT Analysis
  • Table 175 Peak Pharma Solutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 176 Peak Pharma Solutions Inc.: Service Benchmarking
  • Table 177 Promoveo Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 178 Promoveo Health: Service Benchmarking
  • Table 179 Sales Focus Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 180 Sales Focus Inc.: Service Benchmarking
  • Table 181 Sales Focus Inc. Strategic Outlook

List of Figures

  • Figure 1 Pharma Contract Sales Market Segmentation
  • Figure 2 Pharma Contract Sales Market Attractiveness Index by Services
  • Figure 3 Pharma Contract Sales Market Attractiveness Index by Therapeutic Areas
  • Figure 4 Pharma Contract Sales Market Attractiveness Index by End-users
  • Figure 5 Pharma Contract Sales Market Attractiveness Index by Region
  • Figure 6 Pharma Contract Sales Market: Market Dynamics
  • Figure 7 Pharma Contract Sales Market: Impact Analysis
  • Figure 8 Pharma Contract Sales Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 9 Pharma Contract Sales Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 10 Pharma Contract Sales Market by Region, 2025-2035 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 11 Short Term & Long Term Planning
  • Figure 12 Impact of U.S. and China Trade War
  • Figure 13 Most Impacted Countries
  • Figure 14 Pharma Contract Sales Market: Porter's Five Forces Analysis
  • Figure 15 Pharma Contract Sales Market: PEST Analysis
  • Figure 16 Pharma Contract Sales Market by Services: Market Attractiveness Index
  • Figure 17 Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 18 Pharma Contract Sales Share Forecast by Services, 2025, 2030, 2035 (%)
  • Figure 19 Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 20 Personal Promotion Market Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 21 Personal Promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 22 Personal Promotion Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 23 Promotional Sales Team Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 24 Promotional Sales Team Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 25 Key Account Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 26 Key Account Management Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 27 Specialty Sales Teams Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 28 Specialty Sales Teams Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 29 Vacancy Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 30 Vacancy Management Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 31 Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 32 Non-personal Promotion Market Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 33 Non-personal Promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 34 Non-personal Promotion Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 35 Contact Center Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 36 Contact Center Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 37 Tele-detailing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 38 Tele-detailing Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 39 Digital Omnichannel Engagement Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 40 Digital Omnichannel Engagement Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 41 Medical Call Centers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 42 Medical Call Centers Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 43 Patient Support Programs (PSPs) Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 44 Patient Support Programs (PSPs) Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 45 Telesampling Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 46 Telesampling Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 47 Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 48 Co-promotion Market Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 49 Co-promotion Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 50 Co-promotion Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 51 Product Commercialization Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 52 Product Commercialization Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 53 Marketing Research and Consulting Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 54 Marketing Research and Consulting Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 55 Territory Optimisation & Alignment Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 56 Territory Optimisation & Alignment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 57 Market Access and Pricing Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 58 Market Access and Pricing Support Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 59 Brand Management Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 60 Brand Management Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 61 Co-promotion Partnerships Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 62 Co-promotion Partnerships Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 63 Mature Product Line Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 64 Mature Product Line Support Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 65 Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 66 Support Services Market Forecast by Type, 2025, 2030, 2035 (%)
  • Figure 67 Support Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 68 Support Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 69 Training and Compliance Services Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 70 Training and Compliance Services Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 71 Data Analytics and CRM Support Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 72 Data Analytics and CRM Support Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 73 Medical Affairs Outsourcing Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 74 Medical Affairs Outsourcing Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 75 Pharmacovigilance and Safety Monitoring Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 76 Pharmacovigilance and Safety Monitoring Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 77 Pharma Contract Sales Market by Therapeutic Areas: Market Attractiveness Index
  • Figure 78 Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR %)
  • Figure 79 Pharma Contract Sales Share Forecast by Therapeutic Areas, 2025, 2030, 2035 (%)
  • Figure 80 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 81 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 82 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 83 Immunology Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 84 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 85 Diabetes Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 86 Cardiovascular Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 87 Cardiovascular Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 88 Respiratory Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 89 Respiratory Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 90 CNS Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 91 CNS Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 92 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 93 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 94 Pharma Contract Sales Market by End-users: Market Attractiveness Index
  • Figure 95 Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 96 Pharma Contract Sales Share Forecast by End-users, 2025, 2030, 2035 (%)
  • Figure 97 Pharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 98 Pharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 99 Biopharmaceutical Companies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 100 Biopharmaceutical Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
  • Figure 101 Pharma Contract Sales Market Forecast by Region 2025 and 2035 (Revenue, CAGR%)
  • Figure 102 Pharma Contract Sales Market Share Forecast by Region 2025, 2029, 2035 (%)
  • Figure 103 Pharma Contract Sales Market by Region, 2025-2035 (US$ Billion, AGR %)
  • Figure 104 North America Pharma Contract Sales Market Attractiveness Index
  • Figure 105 North America Pharma Contract Sales Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 106 North America Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 107 North America Pharma Contract Sales Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 108 North America Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 109 North America Pharma Contract Sales Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 110 North America Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 111 North America Personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 112 North America Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 113 North America Non-personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 114 North America Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 115 Co-promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 116 North America Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 117 North America Support Services Market Forecast by Type, 2025 & 2035 (%)
  • Figure 118 North America Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR %)
  • Figure 119 North America Pharma Contract Sales Market Share Forecast by Therapeutic Areas, 2025 & 2035 (%)
  • Figure 120 North America Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 121 North America Pharma Contract Sales Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 122 U.S. Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 123 Canada Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 124 Europe Pharma Contract Sales Market Attractiveness Index
  • Figure 125 Europe Pharma Contract Sales Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 126 Europe Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 127 Europe Pharma Contract Sales Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 128 Europe Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 129 Europe Pharma Contract Sales Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 130 Europe Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 131 Europe Personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 132 Europe Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 133 Europe Non-personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 134 Europe Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 135 Co-promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 136 Europe Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 137 Europe Support Services Market Forecast by Type, 2025 & 2035 (%)
  • Figure 138 Europe Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR %)
  • Figure 139 Europe Pharma Contract Sales Market Share Forecast by Therapeutic Areas, 2025 & 2035 (%)
  • Figure 140 Europe Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 141 Europe Pharma Contract Sales Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 142 Germany Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 143 UK Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 144 France Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 145 Italy Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 146 Spain Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 147 Russia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 148 Switzerland Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 149 Belgium Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 150 Rest of Europe Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 151 Asia Pharma Contract Sales Market Attractiveness Index
  • Figure 152 Asia Pharma Contract Sales Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 153 Asia Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 154 Asia Pharma Contract Sales Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 155 Asia Pacific Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 156 Asia Pacific Pharma Contract Sales Market Share Forecast by Services, 2025 & 2035 (%)
  • Figure 157 Asia Pacific Personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 158 Asia Pacific Personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 159 Asia Pacific Non-personal Promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 160 Asia Pacific Non-personal Promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 161 Asia Pacific Co-promotion Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 162 Co-promotion Market Forecast by Type, 2025 & 2035 (%)
  • Figure 163 Asia Pacific Support Services Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
  • Figure 164 Asia Pacific Support Services Market Forecast by Type, 2025 & 2035 (%)
  • Figure 165 Asia Pacific Pharma Contract Sales Market Forecast by Therapeutic Areas, 2025-2035 (US$ Billion, AGR %)
  • Figure 166 Asia Pacific Pharma Contract Sales Market Share Forecast by Therapeutic Areas, 2025 & 2035 (%)
  • Figure 167 Asia Pacific Pharma Contract Sales Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
  • Figure 168 Asia Pacific Pharma Contract Sales Market Share Forecast by End-users, 2025 & 2035 (%)
  • Figure 169 Japan Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 170 China Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 171 India Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 172 Australia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 173 South Korea Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 174 Singapore Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 175 Malaysia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 176 Rest of Asia Pharma Contract Sales Market Forecast, 2025-2035 (US$ Billion, AGR %)
  • Figure 177 Latin America Pharma Contract Sales Market Attractiveness Index
  • Figure 178 Latin America Pharma Contract Sales Market by Region, 2025, 2030 & 2035 (US$ Billion)
  • Figure 179 Latin America Pharma Contract Sales Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
  • Figure 180 Latin America Pharma Contract Sales Market Share Forecast by Country, 2025 & 2035 (%)
  • Figure 181 Latin America Pharma Contract Sales Market Forecast by Services, 2025-2035 (US$ Billion, AGR %)
  • Figure 182 Latin America Pharma Contract Sales Market Share Forecast by Services, 2025 & 2035
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!